Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,074 | 31,994 | 25,173 | 36,964 | 26,827 |
| Receivables | 121,925 | 137,305 | 125,541 | 122,789 | 112,899 |
| Inventories | 90,032 | 87,606 | 97,005 | 91,333 | 97,563 |
| Other current assets | 26,734 | 28,408 | 0 | 0 | 0 |
| TOTAL | $298,688 | $308,883 | $265,903 | $267,999 | $249,452 |
| Non-Current Assets | |||||
| PPE Net | 29,425 | 31,938 | 34,532 | 36,605 | 39,704 |
| Investments And Advances | 1,933 | 2,088 | 3,211 | 3,141 | 6,864 |
| Intangibles | 422,271 | 432,014 | 478,130 | 489,812 | 500,786 |
| Other Non-Current Assets | 17,175 | 17,250 | 12,462 | 13,353 | 14,298 |
| TOTAL | $470,804 | $483,290 | $528,335 | $542,911 | $561,652 |
| Total Assets | $769,492 | $792,173 | $794,238 | $810,910 | $811,104 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 38,566 | 38,566 | 35,811 | 27,848 | 19,584 |
| Accounts payable and accrued liabilities | 16,849 | 24,437 | 19,099 | 23,038 | 17,637 |
| Accrued Expenses | 128,697 | 139,978 | 113,605 | 119,795 | 118,896 |
| Other current liabilities | 27,380 | 28,482 | 4,806 | 4,816 | 4,726 |
| TOTAL | $211,492 | $231,463 | $173,321 | $175,497 | $160,843 |
| Non-Current Liabilities | |||||
| Long Term Debt | 345,021 | 344,716 | 355,430 | 366,998 | 375,033 |
| Other Non-Current Liabilities | 26,829 | 35,467 | 48,252 | 47,644 | 50,260 |
| TOTAL | $371,167 | $371,648 | $403,485 | $414,295 | $423,805 |
| Total Liabilities | $582,659 | $603,111 | $576,806 | $589,792 | $584,648 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 81,155 | 80,974 | 79,614 | 79,166 | 78,753 |
| Common Shares | 81 | 81 | 80 | 79 | 79 |
| Retained earnings | -354,922 | -350,098 | -326,106 | -321,536 | -315,440 |
| Other shareholders' equity | 38,540 | 38,110 | 46,481 | 48,321 | 49,324 |
| TOTAL | $186,833 | $189,062 | $217,432 | $221,118 | $226,456 |
| Total Liabilities And Equity | $769,492 | $792,173 | $794,238 | $810,910 | $811,104 |